GLP-1 medications, like semaglutide (Ozempic, Wegovy), were originally developed to help people with type 2 diabetes manage blood sugar
Reduces the likelihood of forgetting your weekly injection
These differences matter clinically: larger average weight loss translates into bigger improvements in blood pressure, glycemic measures, sleep apnea metrics, mobility, and quality of life for many patients
clinical study showed people lost about 21% of their body weight on average
Ceccarelli E, Guarino E, Merlotti D, Patti A, Luigi G, Nuti R, et al
Financial support and sponsorship The research leading to these results has received funding from MIUR under PNRR M4C2I1.3 Heal Italia project (PE00000019, CUP B73C22001250006) to Petta S